April 9, 2020
AnGes said on April 8 that FunPep, an Osaka University spin-off specializing in the development of a peptide-based vaccine, has decided to chip in to the AnGes-Osaka University initiatives to develop a DNA vaccine against the novel coronavirus infection (COVID-19)...read more